David Joseph Gaffin
Net Worth

Last updated:

What is David Joseph Gaffin net worth?

The estimated net worth of Mr. David Joseph Gaffin is at least $10,718,195 as of 3 Aug 2024. He owns shares worth $2,163,313 as insider, has earned $995,692 from insider trading and has received compensation worth at least $7,559,190 in Alkermes plc.

What is the salary of David Joseph Gaffin?

Mr. David Joseph Gaffin salary is $839,910 per year as Senior Vice President, Chief Legal Officer, Chief Compliance Officer & Sec. in Alkermes plc.

How old is David Joseph Gaffin?

Mr. David Joseph Gaffin is 53 years old, born in 1972.

What stocks does David Joseph Gaffin currently own?

As insider, Mr. David Joseph Gaffin owns shares in one company:

Company Title Shares Price per share Total value
Alkermes plc (ALKS) Senior Vice President, Chief Legal Officer, Chief Compliance Officer & Sec. 74,597 $29 $2,163,313

What does Alkermes plc do?

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS logo
ALKS
Alkermes plc
$29

David Joseph Gaffin insider trading

Alkermes plc

Mr. David Joseph Gaffin has made 7 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 14,000 units of ALKS stock on 29 Jul 2021. As of 3 Aug 2024 he still owns at least 74,597 units of ALKS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Ordinary Shares 2,014 N/A N/A
Option
Restricted Stock Unit Award 2,014 N/A N/A
Option
Ordinary Shares 7,689 N/A N/A
Option
Restricted Stock Unit Award 7,689 N/A N/A
Option
Restricted Stock Unit Award 7,431 N/A N/A
Option
Ordinary Shares 7,431 N/A N/A
Option
Restricted Stock Unit Award 1,974 N/A N/A
Option
Ordinary Shares 1,974 N/A N/A
Option
Ordinary Shares 7,286 N/A N/A
Option
Restricted Stock Unit Award 7,286 N/A N/A
Option
Ordinary Shares 6,875 N/A N/A
Option
Restricted Stock Unit Award 6,875 N/A N/A
Option
Ordinary Shares 7,036 N/A N/A
Option
Restricted Stock Unit Award 7,036 N/A N/A
Option
Ordinary Shares 6,230 N/A N/A
Option
Restricted Stock Unit Award 6,230 N/A N/A
Option
Ordinary Shares 7,286 N/A N/A
Option
Restricted Stock Unit Award 7,036 N/A N/A
Option
Restricted Stock Unit Award 7,286 N/A N/A
Option
Restricted Stock Unit Award 6,875 N/A N/A
Option
Ordinary Shares 6,875 N/A N/A
Option
Ordinary Shares 7,036 N/A N/A
Option
Restricted Stock Unit Award 3,375 N/A N/A
Option
Ordinary Shares 3,375 N/A N/A
Option
Ordinary Shares 14,000 $16.55 $231,700
Option
Employee Stock Option (Right to Buy) 14,000 $16.55 $231,700
Sale
Ordinary Shares 14,000 $16.55 $231,700
Option
Employee Stock Option (Right to Buy) 13,500 $16.55 $223,425
Option
Ordinary Shares 13,500 $16.55 $223,425
Sale
Ordinary Shares 13,500 $16.55 $223,425
Option
Employee Stock Option (Right to Buy) 13,500 $16.55 $223,425
Option
Ordinary Shares 13,500 $16.55 $223,425
Sale
Ordinary Shares 13,500 $16.55 $223,425
Sale
Ordinary Shares 2,250 N/A N/A
Option
Employee Stock Option (Right to Buy) 2,250 N/A N/A
Option
Ordinary Shares 2,250 N/A N/A
Option
Ordinary Shares 6,875 N/A N/A
Option
Restricted Stock Unit Award 6,875 N/A N/A
Option
Restricted Stock Unit Award 7,036 N/A N/A
Option
Ordinary Shares 7,036 N/A N/A
Option
Ordinary Shares 2,500 N/A N/A
Option
Restricted Stock Unit Award 2,500 N/A N/A
Option
Restricted Stock Unit Award 3,375 N/A N/A
Option
Ordinary Shares 3,375 N/A N/A
Option
Ordinary Shares 3,000 $11.74 $35,220
Option
Employee Stock Option (Right to Buy) 3,000 $11.74 $35,220
Option
Restricted Stock Unit Award 2,250 N/A N/A
Option
Ordinary Shares 2,250 N/A N/A
Option
Restricted Stock Unit Award 6,875 N/A N/A
Option
Ordinary Shares 6,875 N/A N/A
Option
Restricted Stock Unit Award 2,500 N/A N/A
Option
Ordinary Shares 2,500 N/A N/A
Option
Restricted Stock Unit Award 3,375 N/A N/A
Option
Ordinary Shares 3,375 N/A N/A
Option
Ordinary Shares 7,000 $8.55 $59,850
Option
Employee Stock Option (Right to Buy) 7,000 $8.55 $59,850
Sale
Ordinary Shares 5,373 $26.87 $144,389
Option
Ordinary Shares 2,250 N/A N/A
Option
Restricted Stock Unit Award 2,250 N/A N/A
Option
Restricted Stock Unit Award 1,100 N/A N/A
Option
Ordinary Shares 1,100 N/A N/A
Option
Ordinary Shares 2,500 N/A N/A
Option
Restricted Stock Unit Award 2,500 N/A N/A
Option
Restricted Stock Unit Award 3,375 N/A N/A
Option
Ordinary Shares 3,375 N/A N/A
Option
Ordinary Shares 275 $12.29 $3,380
Option
Employee Stock Option (Right to Buy) 275 $12.29 $3,380
Option
Ordinary Shares 1,250 N/A N/A
Option
Restricted Stock Unit Award 1,250 N/A N/A
Option
Restricted Stock Unit Award 2,250 N/A N/A
Option
Ordinary Shares 2,250 N/A N/A
Option
Restricted Stock Unit Award 1,100 N/A N/A
Option
Ordinary Shares 1,100 N/A N/A
Option
Ordinary Shares 2,500 N/A N/A
Option
Restricted Stock Unit Award 2,500 N/A N/A
Option
Ordinary Shares 250 $14.13 $3,533
Option
Employee Stock Option (Right to Buy) 250 $14.13 $3,533
Option
Ordinary Shares 1,250 N/A N/A
Option
Restricted Stock Unit Award 1,250 N/A N/A
Option
Employee Stock Option (Right to Buy) 2,250 $15.95 $35,888
Option
Ordinary Shares 2,250 $15.95 $35,888
Option
Restricted Stock Unit Award 1,250 N/A N/A
Option
Ordinary Shares 1,250 N/A N/A
Option
Restricted Stock Unit Award 2,250 N/A N/A
Option
Ordinary Shares 2,250 N/A N/A
Option
Ordinary Shares 1,100 N/A N/A
Option
Restricted Stock Unit Award 1,100 N/A N/A
Option
Employee Stock Option (Right to Buy) 250 $14.13 $3,533
Option
Employee Stock Option (Right to Buy) 2,500 $15.04 $37,600
Option
Ordinary Shares 2,500 $15.04 $37,600
Sale
Ordinary Shares 2,500 $55.4 $138,500
Option
Employee Stock Option (Right to Buy) 3,443 $13.34 $45,912
Option
Ordinary Shares 3,443 $13.34 $45,912
Option
Ordinary Shares 1,600 N/A N/A
Option
Performance Restricted Stock Units 1,600 N/A N/A
Option
Ordinary Shares 2,382 $14.38 $34,253
Option
Employee Stock Option (Right to Buy) 2,382 $14.38 $34,253
Sale
Ordinary Shares 2,382 $14.38 $34,253
Option
Ordinary Shares 1,250 N/A N/A
Option
Restricted Stock Unit Award 1,250 N/A N/A

Alkermes key executives

Alkermes plc executives and other stock owners filed with the SEC: